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Abstract 
Tumor proliferation is an important biomarker indicative of the prognosis of breast cancer 
patients. Assessment of tumor proliferation in a clinical setting is highly subjective and labor-
intensive task. Previous efforts to automate tumor proliferation assessment by image analysis 
only focused on mitosis detection in predefined tumor regions. However, in a real-world 
scenario, automatic mitosis detection should be performed in whole-slide images (WSIs) and 
an automatic method should be able to produce a tumor proliferation score given a WSI as 
input. To address this, we organized the TUmor Proliferation Assessment Challenge 2016 
(TUPAC16) on prediction of tumor proliferation scores from WSIs.  
The challenge dataset consisted of 500 training and 321 testing breast cancer histopathology 
WSIs. In order to ensure fair and independent evaluation, only the ground truth for the training 
dataset was provided to the challenge participants. The first task of the challenge was to predict 
mitotic scores, i.e., to reproduce the manual method of assessing tumor proliferation by a 
pathologist. The second task was to predict the gene expression based PAM50 proliferation 
scores from the WSI.  
The best performing automatic method for the first task achieved a quadratic-weighted Cohen’s 
kappa score of κ = 0.567, 95% CI [0.464, 0.671] between the predicted scores and the ground 
truth. For the second task, the predictions of the top method had a Spearman’s correlation 
coefficient of r = 0.617, 95% CI [0.581 0.651] with the ground truth. 
This was the first study that investigated tumor proliferation assessment from WSIs. The 
achieved results are promising given the difficulty of the tasks and weakly-labelled nature of 
the ground truth. However, further research is needed to improve the practical utility of image 
analysis methods for this task. 
Keywords: breast cancer, cancer prognostication, tumor proliferation, deep learning  
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1. Introduction 
Tumor proliferation is an important biomarker indicative of the prognosis of breast cancer 
patients. Patients with high tumor proliferation have worse outcomes compared to patients with 
low tumor proliferation (van Diest et al., 2004). The assessment of tumor proliferation 
influences the clinical management of the patient – patients with aggressive tumors are treated 
with more aggressive therapies and patients with indolent tumor are given more conservative 
treatments that are preferred because of fewer side-effects (Fitzgibbons et al., 2000).  
Tumor proliferation in a clinical setting is traditionally assessed by pathologists. The most 
common method is to count mitotic figures (dividing cell nuclei) on hematoxylin & eosin 
(H&E) histological slides under a microscope. The pathologists will assign a mitotic score of 
1, 2 or 3, where a score of 3 represents high tumor proliferation. Two other methods to assess 
tumor proliferation include immunohistochemical staining for Ki67 protein (Cheang et al., 
2009) and the molecular gene expression based PAM50 proliferation score (Heng et al., 2017; 
Nielsen et al., 2010; The Cancer Genome Atlas Network, 2012). The PAM50 proliferation 
score was significantly associated with mitotic counts (Heng et al., 2017), however the 
agreement is not perfect. 
Although mitosis counting is routinely performed in most pathology practices, this highly 
subjective and labor-intensive task suffers from reproducibility problems (Veta et al., 2016). 
One solution is to develop automated computational pathology systems to efficiently, 
accurately and reliably detect and count mitotic figures on histopathological images. Mitosis 
detection in WSIs is an active field of research  (Albarqouni et al., 2016; Chen et al., 2016, 
2016; Li et al., 2018; Tellez et al., 2018, 2018b). This interest was in large part supported by 
the availability of public datasets in the form of medical image analysis challenges. The first 
challenge on the topic of on mitosis detection was MITOS 2012 hosted at the International 
Conference of Pattern Recognition (ICPR) 2012 (Roux et al., 2013). In 2013, we organized 
AMIDA13 in conjunction with the International Conference on Medical Image Computing and 
Computer Assisted Intervention (MICCAI) conference (Veta et al., 2015). Mitosis detection 
was also one of the tasks of the MITOS-ATYPIA-14 challenge, organized as part of ICPR 
2014, with the other task being scoring of nuclear atypia (Roux, 2014).  
A large limitation of all previous challenges was that they focused solely on mitosis detection 
in predetermined tumor regions of interest (ROIs). However, in a real-world scenario, 
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automatic mitosis detection should be performed in WSIs and an automatic method should 
ideally be able to produce a breast tumor proliferation score given a WSI as input. To address 
this, we organized the TUmor Proliferation Assessment Challenge 2016 (TUPAC16). The 
main goal of the challenge was to evaluate (semi-)automatic methods to assess tumor 
proliferation from WSIs. In this paper, we present an overview of the submitted methods and 
results of the TUPAC16 challenge.  
1.1 Challenge format and tasks 
The challenge was organized in the context of MICCAI 2016 in Athens, Greece. The 
participants were able to register via the TUPAC16 website1 six months prior to the MICCAI 
2016 conference, allowing ample time to develop their algorithms and submit results. Upon 
registration, the participants were provided with a training and testing dataset to develop an 
automatic tumor proliferation scoring method. Two auxiliary datasets that could aid the method 
development were also provided (see Materials and Methods section). In order to ensure fair 
and independent evaluation, only the ground truth for the training dataset was provided. The 
ground truth for the testing dataset was retained by the challenge organizers. 
The challenge had two main tasks to predict tumor proliferation. The first task was to predict 
mitotic scores. In essence, this task aims to reproduce the most common method of assessing 
tumor proliferation by a pathologist. The second task was to predict the gene expression based 
PAM50 proliferation scores. While it has been previously shown that PAM50 proliferation 
scores correlate with manual mitotic scores (Heng et al., 2017), the goal of this task was to 
determine whether molecular scores can be predicted from tissue morphology/WSIs. A third 
task on mitosis detection was later added to the challenge upon request from the participants. 
This task was similar and related to the AMIDA13 challenge (Veta et al., 2015). However, due 
to the auxiliary nature of this task, we will not include it in the overview of this challenge and 
focus solely on the tumor proliferation assessment from WSIs. 
All participating individuals or teams submitted their results for evaluation on the challenge 
website. In order to prevent overfitting on the test set, the number of submissions was limited 
to three per task. All submitted results before the deadline of October 3rd 2016 were presented 
                                               
1  http://tupac.tue-image.nl 
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at the challenge workshop and are included in this paper. Prior to the submission deadline, 159 
teams registered on the challenge website. Twelve teams submitted results for the first task2 
and six teams submitted results for the second task.  
2. Materials and Methods 
2.1 Main dataset from The Cancer Genome Atlas 
The Cancer Genome Atlas (TCGA) Network was established to understand the molecular basis 
of 33 types of cancer. Specifically, the TCGA breast cancer team utilized genomic, 
transcriptomic and proteomic profiling technologies to characterize over 1200 invasive breast 
cancer cases (The Cancer Genome Atlas Network, 2012). Heng et al. (2017) subsequently 
curated a highly detailed histopathological annotation database for a subset of 850 TCGA 
breast cancer cases and integrated underlying molecular mechanisms with breast cancer 
morphological features.  
Each case in Heng et al. (2017) was represented by one WSI scanned at 40× magnification 
(Gutman et al., 2013). Cases were randomly assigned to a team of 15 international breast 
pathology experts to assess 12 breast cancer morphological features. Most features adhered to 
criteria established in clinical practice (Lester et al., 2009), criteria for certain features had to 
be modified to assess WSIs (Heng et al., 2017). For mitotic scores, the pathologists assigned a 
score of 1 to represent 0 to 5 mitotic counts per 10 high powered frames (HPFS) at 40× 
magnification; a score of 2 to represent 6 to 10 mitotic counts per 10 HPFS; and a score of 3 
for >10 mitotic counts per 10 HPFS. Mitotic scores were available for 821 cases, of which 311 
were scored by at least two pathologists with an inter-rater reliability Krippendorff’s alpha of 
0.488 and 78% agreement (Heng et al., 2017). In the 311 cases scored by more than one 
pathologist, a consensus was formed by taking the most common mitotic score (in case of a tie, 
the highest mitotic score was taken as the consensus). Gene expression based PAM50 
proliferation score was available for all cases. The PAM50 proliferation score is the average 
expression of 11 proliferation-associated genes part of the PAM50 gene signature: BIRC5, 
                                               
2  This overview paper includes he methods of 11 teams. The team with the lowest ranking method for the 
first task asked to be excluded from the overview paper (the results of this team are visible on the challenge 
website).  
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CCNB1, CDC20, CEP55, MKI67, NDC80, NUF2, PTTG1, RRM2, TYMS and UBE2C (Heng 
et al., 2017; Nielsen et al., 2010).  
Therefore, the main challenge dataset consisted of 821 TCGA WSIs with two types of tumor 
proliferation data: mitotic score (manual mitosis counting by the pathologists) and PAM50 
proliferation score (derived from gene expression). These 821 cases were randomly split into 
a training (n = 500) and testing (n = 321) set. In total, there are 383 cases with a mitotic score 
of 1, 194 cases with score 2 and 244 cases with score 3. The mean PAM50 proliferation score 
is -0.176 with a standard deviation of 0.428.  
2.2 Auxiliary datasets 
In addition to the main challenge dataset, two auxiliary datasets (ROI and mitosis detection) 
were also provided to the participants. These two datasets were to facilitate the design of a WSI 
tumor proliferation scoring system, for example, by following a two-step approach to emulate 
how a pathologist would assess a slide for tumor proliferation: identify ROIs followed by 
mitotic counting.  
ROI dataset: The ROI auxiliary dataset contained 148 cases which were randomly selected 
from the training dataset. A blinded pathology resident annotated three ROIs to indicate where 
a pathologist might perform mitosis counting, adhering to standard clinical guidelines (Lester 
et al., 2009). Mitosis counting is performed in tumor regions that have high cellularity and are 
preferably located at the periphery. Note that these ROIs identified by the pathology resident 
may not necessarily overlap with the HPFS used by the team of pathologists who graded the 
mitotic scores in Heng et al. (2017). Examples of ROI annotations by the pathology resident in 
the auxiliary ROI dataset are given in Figure 1. 
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Figure 1 – Examples of two low magnification whole slide images in the auxiliary region of 
interest (ROI) dataset annotated with three ROIs (green rectangle boxes) each by a pathology 
resident. These ROIs represent areas where a pathologist might perform mitosis counting.  
 
Mitosis detection dataset: The mitosis detection dataset consisted of WSIs from 73 breast 
cancer cases from three pathology centers with annotated mitotic figures by consensus of three 
observers. Of the 73 cases, 23 were previously released as part of the AMIDA13 challenge 
(Veta et al., 2015). These cases were collected from the Department of Pathology at the 
University Medical Center in Utrecht, The Netherlands. Each case was represented with 
varying number of HPFS extracted from WSIs acquired with the Aperio ScanScope XT scanner 
at 40× magnification with a spatial resolution of 0.25 µm/pixel. 
The remaining 50 cases previously used to assess the inter-observer agreement for mitosis 
counting were from two other pathology centers in The Netherlands (Symbiant Pathology 
Expert Center, Alkmaar and Symbiant Pathology Expert Center , Zaandam) (Veta et al., 2016). 
Each case was represented by one WSI region with an area of 2 mm2. These WSIs were 
obtained using the Leica SCN400 scanner (40× magnification and spatial resolution of 0.25 
µm/pixel). The annotated mitotic figures are the consensus of at least two pathologists, similar 
to the AMIDA13 challenge. In total, the mitosis detection auxiliary dataset contained 1552 
annotated mitotic figures (Figure 2).  
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Figure 2 – Examples from the mitosis detection auxiliary dataset with annotated mitotic figures 
(green circles). These annotated mitotic figures are the consensus of at least two pathologists. 
2.3 Summary of the submitted methods 
All submitted methods broadly fell into two groups depending on the main strategy to predict 
proliferation scores from WSIs. The first group of methods followed a pathologist’s two-step 
approach: identify ROIs followed by performing mitosis counting within the selected regions. 
The prediction for the tumor proliferation scores was based on the response of the mitosis 
detector. The second group of methods followed a more direct strategy. The first step was also 
ROI detection, however, mitosis detection was not performed and the prediction of tumor 
proliferation scores was based on the overall appearance of the ROIs. All teams followed 
similar strategy for the prediction of both proliferation scores.  
With the exception of one team, all participants/teams used deep convolutional neural networks 
as part of the processing pipeline. Table 1 presents an overview of the main characteristics of 
all submitted methods in the challenge. The remainder of this subsection summarizes the main 
characteristics of the proposed methods. A more detailed description of the individual methods 
can be found in the Supplementary Materials. 
Preprocessing and ROI detection: One of the major hurdles in histopathology image analysis 
is the variability of tissue appearance. The staining color and intensity can be significantly 
different between WSIs due to variation in tissue preparation, staining and digitization 
processes. To address this, the majority of submitted method performed staining normalization 
as a preprocessing step. The most commonly used method was the one proposed by Macenko 
et al. (2009). This unsupervised method heuristically estimates the absorbance coefficients for 
the H&E stains for every image and the staining concentrations for every pixel. Normalization 
was performed by recomposing the RGB images from the staining concentration maps using 
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common absorbance coefficients. 
Since large portions of the WSIs are background, many of the proposed methods resort to tissue 
segmentation by thresholding such as Otsu’s method (Otsu, 1979). The HEIDELBERG team 
also detected artifacts such as marker annotations or tissue folds based on heuristic mapping 
that highlights them. 
The ROI auxiliary dataset contained non-exhaustive annotations of tumor areas where mitosis 
detection can be performed. Two teams used this data to train a one-class classifier. The IBM 
team trained a convolutional autoencoder with the provided ROIs and used the reconstruction 
error as metric to identify ROIs in test images. BELARUS identified ROIs using the L1 
similarity of co-occurrence features to the ground truth ROIs (Kovalev et al., 2001).  
SECTRA and WARWICK made in-house annotations of non-ROI regions and used this data 
to train a supervised ROI detection method (note that the annotated ROIs were used only for 
training). The method proposed by HARKER also trained a supervised model for ROI 
detection, however instead of manual annotation for the negative class, HARKER made the 
assumption that all regions that were not annotated were negative. LUNIT detected ROIs based 
on cell/nuclei density estimated with CellProfiler (Kamentsky et al., 2011).The MICROSOFT 
team used manually selected ROIs annotated by an external pathologist 3. Therefore, their 
method was classified as semi-automatic.  
Mitosis detection: All teams that performed mitosis detection as part of the proliferation 
scoring pipeline used deep convolutional neural networks. Most teams trained a two-class 
classification model: patches centered at a mitotic figure and background patches. On the 
testing dataset, the model evaluated every pixel location and produced a mitosis probability 
map that could be further processed to identify mitotic figures and/or produce a mitotic score 
for a ROI. The neural network architectures applied to this problem vary from relative 
“shallow” networks with only a few convolutional layers (CONTEXTVISION and SECTRA) 
to deep residual neural networks (LUNIT and IBM) (He et al., 2015).  
                                               
3  This additional data and the manually annotated ROIs in the testing set used by the MICROSOFT 
team are available on the TUPAC16 website.  
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The mitosis detection model by HEIDELBERG did not follow the patch-based approach. They 
trained a model that incorporated a Hough voting layer – each pixel location predicted the 
radius and angle to the nearest mitotic figure.  
Since mitoses are generally rare events, even in high grade cancers, the mitosis/background 
classification problem is very unbalanced. In order to remedy this, the majority of submitted 
methods resorted to two strategies. The first strategy was data augmentation by geometric 
transformations of the training samples. The mitosis detection problem is invariant to rotations, 
flipping and small translation and scaling. This can be exploited to create new plausible training 
samples to enrich the training data.  
The other strategy was hard negative mining, which was first proposed for mitosis detection 
by Cireşan et al. (2013). With this boosting-like technique, an initial mitosis detection method 
is trained with random sampling for the background class and then used to detect “difficult” 
negative instances that are used to train a second method. In practice, models trained with 
random sampling for the background class result in a large number of false positives since all 
hyperchromatic objects (e.g. lymphocytes, apoptotic nuclei, necrotic nuclei etc) are detected as 
mitoses. The output of the initial mitosis detection method can be used to sample such difficult 
background samples and train a second mitosis detection method. This commonly leads to 
significant improvements of the mitosis detection accuracy.   
Prediction of tumor proliferation score for Task 1: CONTEXTVISION, SECTRA, 
HEIDELBERG and FLORIDA predicted proliferation scores for the first task with heuristic 
methods based on combining the results from the detection of ROIs and mitoses. For instance, 
CONTEXTVISION computed a proliferation score for every detected ROI by counting the 
number of pixels in the mitosis probability map above a certain threshold value that was 
optimized by cross-validation. A slide-level score was produced by taking the maximum over 
all ROIs. The final prediction was made by quantizing the slide-level score into one of the three 
grades based on the grade distribution in the training set. Similarly, SECTRA computed a ROI 
score that combined the number of detected mitotic figures and the per-pixel average of the 
mitosis detection model. A slide-level score was computed by averaging the scores for all 
detected ROIs and then stratified into three categories using two threshold values optimized on 
the training set. HEIDELBERG computed a slide-level proliferation score as the 95th-percentile 
of the mitotic counts for the detected ROIs. 
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LUNIT, IBM, HARKER and WARWICK predicted the proliferation score with a classifier 
that used a combination of features based on the output of the mitosis detection method and 
global ROI features. LUNIT trained a support vector machine (SVM) classification model 
using a set of features that summarized the statistics of the number of detected mitoses and 
nuclei in 30 ROIs. IBM trained a random forest classifier using global color and texture features 
(average intensity of the RGB channels, contrast, energy and homogeneity) and number of 
detected mitoses at four different detection levels in six ROIs.  
Three of the proposed methods (BELARUS, RADBOUD and MICROSOFT) followed a direct 
strategy for predicting proliferation scores that did not rely on mitosis detection. BELARUS 
was the only team that did not employ deep neural networks in any part of the processing 
pipeline and predicted the tumor proliferation score with a linear classifier trained with a set of 
co-occurrence features (Kovalev et al., 2001). The method submitted by RADBOUD was 
unique among the submissions since it did not rely on ROI detection. Instead, large image 
patches from a low magnification level of the WSI (4096´4096 pixels, 5´ magnification) were 
cropped with data augmentation and used as input into a deep neural network model to predict 
the proliferation score. MICROSOFT computed features in the manually annotated ROIs with 
a pre-trained ResNet model (He et al., 2015) and then trained a RankSVM (Joachims, 2002) 
with a linear kernel to make the predictions.  
Prediction of proliferation score for Task 2: All five teams that participated in the second 
task used a similar or identical approach as for the first task, e.g. by using a regression instead 
of a classification model. 
2.4 Evaluation 
The first task was evaluated using the quadratic weighted Cohen’s kappa statistic for inter-rater 
agreement between the ground truth and the predictions. This variant of Cohen’s kappa puts 
higher weight on larger errors in the predicted grade (e.g. “1” instead of “3” or vice versa) that 
are of higher clinical consequence. The second task was evaluated with the Spearman’s 
correlation coefficient between the prediction and the ground truth PAM50 proliferation scores.  
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Table 1 – Summary of the submitted methods. 
Team name Use of 
additional 
training data 
Preprocessing ROI detection Mitosis detection Predictions for Task 1 Predictions for Task 2 
LUNIT 
 
Lunit Inc., Korea  
No Tissue segmentation 
with Otsu 
thresholding (Otsu, 
1979); staining 
normalization 
(Macenko et al., 
2009) 
Based on cell density 
estimated with 
CellProfiler 
(Kamentsky et al., 
2011) 
ResNet architecture 
(He et al., 2015); 
hard negative 
mining  
SVM classifier with 21 types of 
features related to cell and 
mitotic figures density 
SVM for regression, same 
features as for Task 1 
CONTEXTVISION 
 
Contextvision, Sweden 
(SLDESUTO-BOX)
  
No None Based on heuristic 
mapping of the color 
channels that highlights 
dark tumor areas 
Architecture similar 
to Cireşan et al. 
(2013); hard 
negative mining 
Heuristic based on the response 
on mitosis detection in the ROIs 
Same as for Task 1 
SECTRA 
 
Sectra, Sweden  
Yes; non-ROI 
annotations 
None Based on classification 
with a four-layer CNN 
Six-layer CNN; 
hard negative 
mining 
Heuristic based on the response 
on mitosis detection in the ROIs 
d.n.p. 
HEIDELBERG 
 
University of Heidelberg, 
Germany  
No Artifact detection 
based on heuristic 
mapping of the 
color channels that 
highlights ink and 
tissue folding 
Based on heuristic 
mapping of the color 
channels that highlights 
dark tumor areas  
 
 
Novel architecture 
that combine 
residual networks 
with Hough voting 
(Wollmann and 
Rohr, 2017); hard 
negative mining 
Thresholds for the number of 
detected mitotic figures 
optimized using the quadratic 
weighted Cohen’s kappa score 
d.n.p. 
IBM 
 
IBM Research Zurich 
and Brazil 
Yes; ICPR 
2012 and 2014 
datasets 
Staining 
normalization 
(Macenko et al., 
2009) 
One-class classification 
based on the 
reconstruction error of 
convolutional 
autoencoders 
Wide residual 
network 22-2 
architecture 
(Zagoruyko and 
Komodakis, 2016); 
hard negative 
mining 
Random forest classifier using 
color, texture and number of 
mitoses features in the detected 
ROIs 
d.n.p. 
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HARKER 
 
The Harker School, 
United States  
No Tissue segmentation 
with Otsu 
thresholding (Otsu, 
1979); staining 
normalization 
(Ehteshami 
Bejnordi et al., 
2015) 
Based on classification 
with four neural 
network architectures: 
GoogLeNet (Szegedy et 
al., 2014), ResNet-34 
(He et al., 2015), VGG-
13 (Simonyan and 
Zisserman, 2014) and 
custom architecture 
Custom CNN 
architecture; hard 
negative mining; 
end-to-end models 
for predicting the 
mitotic score from 
the ROIs 
Combination random forest, 
SVM and gradient boosting 
classifiers using a combination 
of features from the ROI 
detection, mitosis detection and 
end-to-end models 
Regression with the same 
features as for Task 1 
BELARUS 
 
Belarus National 
Academy of Sciences
  
No Staining 
decomposition; the 
hematoxylin 
channel was used in 
all subsequent 
processing 
One-class classification 
based on L1 similarity 
with co-occurrence 
features (Kovalev et al., 
2001) 
n/a 
 
Direct prediction using a linear 
classifier with co-occurrence 
features (average of prediction 
for 20 ROIs) 
Regression with the same 
features as for Task 1 
RADBOUD 
 
Radboud UMC 
Nijmegen, The 
Netherlands  
No Tissue detection 
with thresholding; 
Staining 
normalization 
(Ehteshami 
Bejnordi et al., 
2015) 
n/a n/a End-to-end prediction using a 
custom CNN architecture 
(average of 500 predictions for 
randomly cropped regions) 
Same as for Task 1 
FLORIDA 
 
University of South 
Florida, United States 
No Staining 
normalization 
(Macenko et al., 
2009) 
Based on heuristic 
mapping of the color 
channels that highlights 
dark tumor areas 
AlexNet 
architecture 
(Krizhevsky et al., 
2012) 
Heuristic thresholds for the 
number of detected mitotic 
figures in the ROIs 
d.n.p. 
WARWICK 
 
University of Warwick, 
United Kingdom  
Yes; non-ROI 
annotations 
None Based on tumor 
segmentation with U-
Net-like architecture 
(Ronneberger et al., 
2015)  
Two-stage CNN 
detector 
Random forest classifier using 
number of mitoses features in 
the detected ROIs 
 
d.n.p. 
MICROSOFT  
 
Microsoft Research Asia, 
China  
No Staining 
normalization 
(Macenko et al., 
2009) 
Manual ROI selection n/a RankSVM with linear kernel 
(Joachims, 2002); feature 
extraction was done with 
ResNet (He et al., 2015) and P-
norm pooling(Xu et al., 2015) 
Same as for Task 1 
 
d.n.p. – did not participate for this task 
n/a - not applicable for this method  
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3. Results 
The results for the first task in the challenge (prediction of tumor proliferation score based on 
mitosis counting) are summarized in Table 2. The top performing method was by LUNIT with 
a quadratic weighted kappa statistic of κ = 0.567, 95% CI [0.464, 0.671]. The semi-automatic 
method by MICROSOFT and the method submitted by CONTEXTVISION had similar 
performances of κ = 0.543, 95% CI [0.422, 0.664] and κ = 0.534, 95% CI [0.422, 0.646], 
respectively. Table 3 presents the confusion matrices of the predictions using the methods by 
LUNIT, MICROSOFT and CONTEXTVISION (the confusion matrices for all methods can be 
found in the Supplementary Materials). As evident by the per-class accuracies, mitotic score 2 
was the most commonly misclassified (per-class accuracy of 17%, 50% and 31% for LUNIT, 
MICROSOFT and CONTEXTVISION).  
Table 2 – Results for Task 1.  
 Team κ † 95% CI 
1 LUNIT 0.567 [0.464, 0.671] 
2 MICROSOFT* 0.543 [0.422, 0.664] 
3 CONTEXTVISION 0.534 [0.422, 0.646] 
4 SECTRA 0.462 [0.340, 0.584] 
5 HEIDELBER 0.417 [0.293, 0.540] 
6 IBM 0.385 [0.266, 0.504] 
7 HARKER 0.367 [0.242, 0.492] 
8 BELARUS 0.321 [0.190, 0.452] 
9 RADBOUD 0.290 [0.171, 0.409] 
10 FLORIDA 0.177 [0.052, 0.302] 
11 WARWICK 0.159 [0.023, 0.294] 
* Semi-automatic method 
† Quadratic weighted Cohen’s kappa statistic 
 
Table 4 summarizes the results of PAM50 proliferation score prediction. The best performance 
was achieved by the semi-automatic method by MICROSOFT (r = 0.710, 95% CI [0.681 
0.737]). The best scoring automatic method was LUNIT with a Spearman correlation 
coefficient between the ground truth and predicted scores of r = 0.617, 95% CI [0.581 0.651], 
followed by RADBOUD with r = 0.516, 95% CI [0.474 0.556]. The scatterplots between the 
ground truth and predicted PAM50 proliferation scores for the MICROSOFT, LUNIT and 
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RADBOUD methods are in Figure 3 (scatterplots for all methods can be found in the 
Supplementary Materials).  
 
Table 3 –Confusion matrices for the LUNIT (A), MICROSOFT (B) and CONTEXTVISION 
(C) methods and the average voting of the top three automatic methods (LUNIT, 
CONTEXTVISION and SECTRA; D). 
 LUNIT  MICROSOFT* 
A  
 
Predicted   
1 2 3 Acc. 
Ground 
truth 
1 117 11 19 80% 
2 40 13 24 17% 
3 16 8 73 75% 
 
B  
 
Predicted   
1 2 3 Acc. 
Ground 
truth 
1 99 44 4 67% 
2 26 39 12 50% 
3 11 46 40 41% 
 
 κ = 0.567 
95% CI [0.464, 0.671] 
 
 κ = 0.543 
95% CI [0.422, 0.664] 
 CONTEXTVISION  Average voting of LUNIT, 
CONTEXTVISION and SECTRA 
C  
 
Predicted   
1 2 3 Acc. 
Ground 
truth 
1 103 29 15  70% 
2 35 24 18 31% 
3 14 22 61 62% 
 
D  
 
Predicted   
1 2 3 Acc. 
Ground 
truth 
1 107 36 4 73% 
2 36 29 12 38% 
3 7 40 50 52% 
 
 κ = 0.534 
95% CI [0.422, 0.646] 
 κ = 0.613 
95% CI [0.504, 0.722] 
 
* Semi-automatic method 
Acc. – per-class accuracy for the three mitotic scores 
 
Table 4 – Results for Task 2.  
 Team r† 95% CI 
1 MICROSOFT* 0.710 [0.681 0.737] 
2 LUNIT 0.617 [0.581 0.651] 
3 RADBOUD 0.516 [0.474 0.556] 
4 CONTEXTVISION 0.503 [0.460 0.544] 
5 BELARUS 0.494 [0.451 0.535] 
6 HARKER 0.474 [0.429 0.516] 
* Semi-automatic method 
† Spearman correlation coefficient 
 
3.1 Method ensembling 
Exploratory experiments with model ensembling were performed by averaging the results of 
the top three automatic methods (the semi-automatic methods by MICROSOFT were excluded 
from this analysis). For the first task, the predicted scores from the top three automatic methods 
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(LUNIT, CONTEXTVISION and SECTRA) were averaged and rounded to the nearest integer. 
This resulted in an improved score of κ = 0.613, 95% CI [0.504, 0.722]. For the second task, 
the predictions by the top three automatic methods (LUNIT, RADBOUD and 
CONTEXTVISION) were first scaled to zero-mean and unit-variance and then averaged. This 
was necessary in order to account for the different scales of the predictions. The combined 
prediction resulted in a Spearman correlation coefficient of r = 0.682, 95% CI [0.651 0.711], 
which is an improvement over the individual prediction (Figure 3D).  
4. Discussion 
Tumor proliferation is an important pathological assessment that aids the clinical management 
of cancer patients. The current method to assess tumor proliferation is manual mitosis counting 
by pathologists. This process is highly subjective and time consuming. An automatic 
computational pathology proliferation assessment method will save time and lead to the 
standardization of mitotic scores across institutions. The TUPAC16 challenge was created to 
advance the state of the art in automatic assessment of tumor proliferation from WSIs and 
improve upon previous challenges that focused solely on mitosis detection. 
The first task of the challenge was to predict a mitosis-based tumor proliferation score. The 
best performing method (LUNIT) achieved a quadratic-weighted Cohen’s kappa score of κ = 
0.567, which signifies a moderate agreement with the manual ground truth. This κ score was 
lower compared to previous work. In Veta et al. (2016), the inter-observer agreement between 
pathologists was estimated between κ = 0.792 and κ = 0.893. The higher κ agreement in 
Veta et al. was most likely due to the three pathologists performing mitosis counting in a 
predefined area, which considerably increases the chances for a concordant score as it 
eliminates the tumor heterogeneity factor, compared to the first task of the challenge where 
the teams may have predicted mitotic scores in ROIs different from the pathologists in Heng et 
al. (2017). All three best performing methods for the first task also made a substantial number 
of errors whereby the predicted and ground truth scores differed by two (Table 3). Such 
discordance may lead to more severe clinical implications, however similar errors can also 
potentially occur with manual scoring (Al-Janabi et al., 2013; Robbins et al., 1995), although 
to a lesser extent. 
The manual scoring of tumor proliferation by mitosis counting involves a multi-scale analysis 
of the tissue. Thus, training an automatic method that predicts mitotic scores using only global, 
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slide-level annotations is a challenging task. It should also be noted that the mitosis detection 
auxiliary dataset, which was used by the majority of teams to train a mitosis detector that 
formed the basis of the proliferation scoring models, was obtained from three Dutch medical 
centers and are different from the TCGA American centers that provided the main dataset. This 
constitutes a domain shift when the mitosis detector trained with the auxiliary dataset is applied 
to main dataset, which further increases the difficulty of this task. 
The top performing automatic methods in the first task followed a two-stage approach that 
emulates the scoring by pathologists. However, the individual building blocks vary between 
the methods. While the method by LUNIT performs mitosis detection with a very deep ResNet 
architecture (He et al., 2015), the methods by SECTRA and CONTEXTVISION that achieved 
a comparable performance used a comparatively “shallower” neural network architecture. 
LUNIT use a staining normalization approach (Macenko et al., 2009) to standardize the 
appearance of the tissue prior to further processing and the mitosis detector used by SECTRA 
works on grayscale images at a two times reduced resolution (0.5 µm/pixel). The top three 
automatic methods for the first task used different ROI detection methods (heuristic color 
channel mapping, cell-density based detection and CNN classifier) and different methods for 
computing a slide-level proliferation score (SVM classifier, heuristic based on the response of 
the mitosis detector). The varied method design is likely responsible for the performance boost 
when ensembling the predictions of the top three methods (κ = 0.613 for the average voting).   
The second task of the challenge has the built-in hypothesis that the molecular PAM50 
proliferation score can be predicted from WSIs. The MICROSOFT, NIJMEGEN and 
BELARUS methods predicted the tumor proliferation scores for both tasks using region-level 
features, without resorting to mitosis detection as an intermediate step. Although their methods 
worked particularly well for the second task and achieved good correlation, the best performing 
automatic method by LUNIT still relied on mitosis counting.   
The performance of the automatic and semi-automatic methods submitted to this challenge 
does not reach a level that is sufficient to be used as a “second opinion” score. The challenge 
setup did not enable the assessment of the disagreement between manual mitosis scoring and 
automatic methods due to the differences in the ROI selection. 
In conclusion, this is the first study to investigate tumor proliferation assessment from WSIs. 
The results are promising given the difficulty of the tasks and weakly-labelled nature of the 
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ground truth. However, further research is needed to improve the practical utility of image 
analysis methods, especially to assess tumor proliferation. A particularly interesting finding of 
this challenge was that both proliferation scores can be predicted with reasonable accuracy 
from ROI-level features, without resorting to mitosis detection. Future research efforts should 
focus on investigating the relationship between global or regional image features and tumor 
proliferation. This can be particularly of interest for the PAM50 proliferation score as it can 
establish a relationship between molecular and morphological tissue characteristics. Domain-
adaptation techniques that can improve the accuracy of mitosis detection when applied to data 
from external centers should also be investigated in the context of this challenge dataset.  
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A 
 
B 
 
  
r = 0.710, 95% CI [0.681 0.737] 
 
  
r = 0.617, 95% CI [0.581 0.651] 
 
C 
 
 
D 
 
  
r = 0.516, 95% CI [0.474 0.556] 
  
r = 0.682, 95% CI [0.651 0.711] 
 
Figure 3 – Results for Task 2. Scatter plots for the MICROSOFT (A), LUNIT (B) and 
RADBOUD (C) methods and the average voting of the top three automatic methods (LUNIT, 
RADBOUD and CONTEXTVISION; D).  
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Supplementary Material 
S1 Method description, available at: 
http://tupac.tue-image.nl/system/files/Supplementary%20material%201.pdf 
S2 Results for all submitted methods, available at: 
http://tupac.tue-image.nl/system/files/Supplementary%20material%202.pdf 
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